fanta.bio Sample: CNhs11968
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
16758 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1063 / 11500 (9.2%) | 310 / 115000 (0.3%) | −324.0 | −324.0 | 34.29 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1565 / 11500 (13.6%) | 525 / 115000 (0.5%) | −324.0 | −324.0 | 29.81 |
| HIF1A SRX11007095 | HK-2 Kidney | 2007 / 11500 (17.5%) | 686 / 115000 (0.6%) | −324.0 | −324.0 | 29.26 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1306 / 11500 (11.4%) | 612 / 115000 (0.5%) | −324.0 | −324.0 | 21.34 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1843 / 11500 (16.0%) | 907 / 115000 (0.8%) | −324.0 | −324.0 | 20.32 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1778 / 11500 (15.5%) | 925 / 115000 (0.8%) | −324.0 | −324.0 | 19.22 |
| SCML2 SRX644728 | 293 Kidney | 1068 / 11500 (9.3%) | 597 / 115000 (0.5%) | −324.0 | −324.0 | 17.89 |
| FOXP1 SRX736067 | LNCAP Prostate | 1388 / 11500 (12.1%) | 900 / 115000 (0.8%) | −324.0 | −324.0 | 15.42 |
| BRD4 SRX9419935 | BT-474 Breast | 2965 / 11500 (25.8%) | 2051 / 115000 (1.8%) | −324.0 | −324.0 | 14.46 |
| MYH11 SRX265221 | ME-1 Blood | 662 / 11500 (5.8%) | 465 / 115000 (0.4%) | −324.0 | −324.0 | 14.24 |
| MED1 SRX9419945 | BT-474 Breast | 2896 / 11500 (25.2%) | 2044 / 115000 (1.8%) | −324.0 | −324.0 | 14.17 |
| MED1 SRX9419944 | BT-474 Breast | 2855 / 11500 (24.8%) | 2036 / 115000 (1.8%) | −324.0 | −324.0 | 14.02 |
| BRD4 SRX9419937 | BT-474 Breast | 2922 / 11500 (25.4%) | 2092 / 115000 (1.8%) | −324.0 | −324.0 | 13.97 |
| BRD4 SRX9419936 | BT-474 Breast | 2956 / 11500 (25.7%) | 2159 / 115000 (1.9%) | −324.0 | −324.0 | 13.69 |
| BRD4 SRX9419938 | BT-474 Breast | 2948 / 11500 (25.6%) | 2158 / 115000 (1.9%) | −324.0 | −324.0 | 13.66 |
| MED1 SRX9419946 | BT-474 Breast | 2955 / 11500 (25.7%) | 2176 / 115000 (1.9%) | −324.0 | −324.0 | 13.58 |
| MED1 SRX9419947 | BT-474 Breast | 2861 / 11500 (24.9%) | 2151 / 115000 (1.9%) | −324.0 | −324.0 | 13.30 |
| EZH2 SRX2146136 | LNCAP Prostate | 6068 / 11500 (52.8%) | 5905 / 115000 (5.1%) | −324.0 | −324.0 | 10.28 |
| BRD4 SRX736201 | 90-8TL Neural | 4758 / 11500 (41.4%) | 4820 / 115000 (4.2%) | −324.0 | −324.0 | 9.87 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1327 / 11500 (11.5%) | 1937 / 115000 (1.7%) | −324.0 | −324.0 | 6.85 |
| PBX4 SRX2731658 | PC-3 Prostate | 443 / 11500 (3.9%) | 18077 / 115000 (15.7%) | −324.0 | −324.0 | 0.25 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1333 / 11500 (11.6%) | 3518 / 115000 (3.1%) | −314.5 | −311.3 | 3.79 |
| 5-mC SRX882970 | LNCAP Prostate | 2470 / 11500 (21.5%) | 10408 / 115000 (9.1%) | −311.4 | −308.3 | 2.37 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 638 / 11500 (5.5%) | 664 / 115000 (0.6%) | −307.4 | −304.3 | 9.61 |
| TP53 SRX19538279 | Osteoblasts Bone | 452 / 11500 (3.9%) | 210 / 115000 (0.2%) | −304.5 | −301.4 | 21.52 |
| 5-mC SRX882968 | LNCAP Prostate | 2420 / 11500 (21.0%) | 10353 / 115000 (9.0%) | −295.6 | −292.5 | 2.34 |
| AGO2 SRX4708039 | Hep G2 Liver | 1558 / 11500 (13.5%) | 5061 / 115000 (4.4%) | −285.7 | −282.6 | 3.08 |
| HIF1A SRX20663235 | HK-2 Kidney | 428 / 11500 (3.7%) | 207 / 115000 (0.2%) | −284.5 | −281.4 | 20.68 |
| RUNX1 SRX2513054 | 293 Kidney | 2632 / 11500 (22.9%) | 12058 / 115000 (10.5%) | −283.4 | −280.4 | 2.18 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1067 / 11500 (9.3%) | 2558 / 115000 (2.2%) | −276.6 | −273.6 | 4.17 |
| 5-mC SRX882965 | LNCAP Prostate | 1995 / 11500 (17.3%) | 8045 / 115000 (7.0%) | −265.5 | −262.5 | 2.48 |
| TP53 SRX19538268 | U2OS Bone | 363 / 11500 (3.2%) | 130 / 115000 (0.1%) | −263.4 | −260.4 | 27.92 |
| TP53 SRX19538274 | U2OS Bone | 362 / 11500 (3.1%) | 133 / 115000 (0.1%) | −260.9 | −257.9 | 27.22 |
| TP53 SRX19538276 | U2OS Bone | 355 / 11500 (3.1%) | 134 / 115000 (0.1%) | −253.9 | −250.9 | 26.49 |
| YAP1 SRX757325 | H2052 Lung | 343 / 11500 (3.0%) | 13944 / 115000 (12.1%) | −253.8 | −250.8 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 316 / 11500 (2.7%) | 13313 / 115000 (11.6%) | −248.4 | −245.4 | 0.24 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1724 / 11500 (15.0%) | 6586 / 115000 (5.7%) | −248.4 | −245.4 | 2.62 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 294 / 11500 (2.6%) | 12819 / 115000 (11.1%) | −245.1 | −242.2 | 0.23 |
| FOS SRX150478 | MCF 10A Breast | 342 / 11500 (3.0%) | 13676 / 115000 (11.9%) | −245.0 | −242.0 | 0.25 |
| TP53 SRX19538273 | U2OS Bone | 328 / 11500 (2.9%) | 116 / 115000 (0.1%) | −238.7 | −235.8 | 28.28 |
| TP53 SRX19538280 | Osteoblasts Bone | 349 / 11500 (3.0%) | 156 / 115000 (0.1%) | −237.6 | −234.7 | 22.37 |
| TP53 SRX19538267 | U2OS Bone | 328 / 11500 (2.9%) | 120 / 115000 (0.1%) | −236.6 | −233.7 | 27.33 |
| KAT6A SRX20971022 | Fibroblasts Others | 282 / 11500 (2.5%) | 56 / 115000 (0.0%) | −232.6 | −229.7 | 50.36 |
| IRF3 SRX11453858 | Hep G2 Liver | 287 / 11500 (2.5%) | 63 / 115000 (0.1%) | −232.4 | −229.6 | 45.56 |
| YAP1 SRX757326 | H2052 Lung | 298 / 11500 (2.6%) | 12435 / 115000 (10.8%) | −229.1 | −226.3 | 0.24 |
| TP53 SRX19538275 | U2OS Bone | 325 / 11500 (2.8%) | 136 / 115000 (0.1%) | −225.7 | −222.8 | 23.90 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 453 / 11500 (3.9%) | 444 / 115000 (0.4%) | −224.6 | −221.7 | 10.20 |
| TP53 SRX19538269 | U2OS Bone | 399 / 11500 (3.5%) | 301 / 115000 (0.3%) | −224.1 | −221.3 | 13.26 |
| TP53 SRX19538281 | Osteoblasts Bone | 366 / 11500 (3.2%) | 225 / 115000 (0.2%) | −223.4 | −220.6 | 16.27 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 522 / 11500 (4.5%) | 669 / 115000 (0.6%) | −221.9 | −219.1 | 7.80 |
| FOXA1 SRX4815198 | MCF-7 Breast | 552 / 11500 (4.8%) | 16375 / 115000 (14.2%) | −220.3 | −217.5 | 0.34 |
| CIC SRX13262055 | Astrocytes Neural | 2341 / 11500 (20.4%) | 11327 / 115000 (9.8%) | −219.3 | −216.5 | 2.07 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 455 / 11500 (4.0%) | 497 / 115000 (0.4%) | −212.6 | −209.8 | 9.15 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 506 / 11500 (4.4%) | 668 / 115000 (0.6%) | −211.0 | −208.2 | 7.57 |
| FOXA1 SRX4815197 | MCF-7 Breast | 390 / 11500 (3.4%) | 13467 / 115000 (11.7%) | −210.4 | −207.6 | 0.29 |
| FOS SRX4192880 | MCF 10A Breast | 246 / 11500 (2.1%) | 10848 / 115000 (9.4%) | −206.9 | −204.1 | 0.23 |
| Epitope tags SRX10549776 | K-562 Blood | 1115 / 11500 (9.7%) | 3550 / 115000 (3.1%) | −206.1 | −203.3 | 3.14 |
| FOXA1 SRX176862 | MCF-7 Breast | 179 / 11500 (1.6%) | 9417 / 115000 (8.2%) | −201.5 | −198.7 | 0.19 |
| FOXA1 SRX3931044 | MCF-7 Breast | 351 / 11500 (3.1%) | 12532 / 115000 (10.9%) | −201.2 | −198.5 | 0.28 |
| TP53 SRX19538270 | U2OS Bone | 369 / 11500 (3.2%) | 302 / 115000 (0.3%) | −199.7 | −197.0 | 12.22 |
| IRF3 SRX11453861 | Hep G2 Liver | 252 / 11500 (2.2%) | 64 / 115000 (0.1%) | −198.2 | −195.5 | 39.38 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1396 / 11500 (12.1%) | 5351 / 115000 (4.7%) | −196.6 | −193.9 | 2.61 |
| TRP47 SRX4548329 | THP-1 Blood | 1998 / 11500 (17.4%) | 9403 / 115000 (8.2%) | −195.3 | −192.6 | 2.12 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 609 / 11500 (5.3%) | 16414 / 115000 (14.3%) | −194.9 | −192.2 | 0.37 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 310 / 11500 (2.7%) | 192 / 115000 (0.2%) | −188.6 | −185.9 | 16.15 |
| FOS SRX150517 | MCF 10A Breast | 279 / 11500 (2.4%) | 10875 / 115000 (9.5%) | −187.4 | −184.7 | 0.26 |
| ESR1 SRX7624157 | MCF-7 Breast | 462 / 11500 (4.0%) | 13892 / 115000 (12.1%) | −186.9 | −184.2 | 0.33 |
| FOXA1 SRX176863 | MCF-7 Breast | 177 / 11500 (1.5%) | 8963 / 115000 (7.8%) | −186.6 | −183.9 | 0.20 |
| SREBF2 SRX5359048 | HCC70 Breast | 1353 / 11500 (11.8%) | 5261 / 115000 (4.6%) | −185.7 | −183.0 | 2.57 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1099 / 11500 (9.6%) | 3730 / 115000 (3.2%) | −185.3 | −182.6 | 2.95 |
| FOXA1 SRX1161177 | MCF-7 Breast | 138 / 11500 (1.2%) | 8143 / 115000 (7.1%) | −185.3 | −182.6 | 0.17 |
| RELA SRX2207673 | HUVEC Cardiovascular | 696 / 11500 (6.1%) | 17336 / 115000 (15.1%) | −184.6 | −181.9 | 0.40 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 424 / 11500 (3.7%) | 13190 / 115000 (11.5%) | −183.8 | −181.1 | 0.32 |
| BRD4 SRX736204 | 90-8TL Neural | 759 / 11500 (6.6%) | 1921 / 115000 (1.7%) | −183.6 | −181.0 | 3.95 |
| GATA3 SRX190239 | MCF-7 Breast | 230 / 11500 (2.0%) | 9850 / 115000 (8.6%) | −182.6 | −179.9 | 0.23 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 171 / 11500 (1.5%) | 8732 / 115000 (7.6%) | −182.5 | −179.9 | 0.20 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 632 / 11500 (5.5%) | 16299 / 115000 (14.2%) | −181.6 | −178.9 | 0.39 |
| AGO2 SRX6783957 | Hep G2 Liver | 975 / 11500 (8.5%) | 3080 / 115000 (2.7%) | −181.1 | −178.5 | 3.17 |
| JUNB SRX8488088 | SUM 229PE Breast | 333 / 11500 (2.9%) | 11587 / 115000 (10.1%) | −180.2 | −177.6 | 0.29 |
| TP53 SRX19538271 | U2OS Bone | 510 / 11500 (4.4%) | 854 / 115000 (0.7%) | −179.6 | −177.0 | 5.97 |
| FOS SRX150476 | MCF 10A Breast | 295 / 11500 (2.6%) | 10911 / 115000 (9.5%) | −179.3 | −176.7 | 0.27 |
| TP53 SRX19538282 | Osteoblasts Bone | 314 / 11500 (2.7%) | 228 / 115000 (0.2%) | −179.1 | −176.5 | 13.77 |
| ESR1 SRX371478 | MCF-7 Breast | 208 / 11500 (1.8%) | 9283 / 115000 (8.1%) | −177.0 | −174.4 | 0.22 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 181 / 11500 (1.6%) | 8769 / 115000 (7.6%) | −177.0 | −174.4 | 0.21 |
| RELA SRX2207672 | HUVEC Cardiovascular | 773 / 11500 (6.7%) | 18164 / 115000 (15.8%) | −177.0 | −174.4 | 0.43 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 297 / 11500 (2.6%) | 10850 / 115000 (9.4%) | −176.2 | −173.6 | 0.27 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 203 / 11500 (1.8%) | 9155 / 115000 (8.0%) | −175.8 | −173.3 | 0.22 |
| YAP1 SRX5718140 | 293 Kidney | 292 / 11500 (2.5%) | 10747 / 115000 (9.3%) | −175.7 | −173.2 | 0.27 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 392 / 11500 (3.4%) | 12415 / 115000 (10.8%) | −175.7 | −173.1 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 273 / 11500 (2.4%) | 10377 / 115000 (9.0%) | −174.4 | −171.8 | 0.26 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 243 / 11500 (2.1%) | 9845 / 115000 (8.6%) | −174.4 | −171.8 | 0.25 |
| AGO2 SRX6783958 | Hep G2 Liver | 942 / 11500 (8.2%) | 2998 / 115000 (2.6%) | −173.0 | −170.5 | 3.14 |
| AR SRX1067071 | LHSAR Prostate | 358 / 11500 (3.1%) | 11734 / 115000 (10.2%) | −171.8 | −169.2 | 0.31 |
| MITF SRX1555436 | 501A Epidermis | 1493 / 11500 (13.0%) | 6414 / 115000 (5.6%) | −171.6 | −169.0 | 2.33 |
| ESR1 SRX20282961 | MCF-7 Breast | 206 / 11500 (1.8%) | 9081 / 115000 (7.9%) | −171.3 | −168.8 | 0.23 |
| FOXA1 SRX371482 | MCF-7 Breast | 253 / 11500 (2.2%) | 9927 / 115000 (8.6%) | −171.2 | −168.6 | 0.25 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 449 / 11500 (3.9%) | 13164 / 115000 (11.4%) | −170.9 | −168.4 | 0.34 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 251 / 11500 (2.2%) | 9840 / 115000 (8.6%) | −169.4 | −166.9 | 0.26 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1271 / 11500 (11.1%) | 5012 / 115000 (4.4%) | −169.4 | −166.9 | 2.54 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 469 / 11500 (4.1%) | 13419 / 115000 (11.7%) | −169.2 | −166.7 | 0.35 |
| SMARCA2 SRX8119677 | MeT-5A Others | 282 / 11500 (2.5%) | 10375 / 115000 (9.0%) | −169.1 | −166.6 | 0.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 112 / 11500 (1.0%) | 7148 / 115000 (6.2%) | −169.0 | −166.5 | 0.16 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1395 / 11500 (12.1%) | 5821 / 115000 (5.1%) | −168.8 | −166.2 | 2.40 |
| TLE3 SRX4815191 | MCF-7 Breast | 153 / 11500 (1.3%) | 7959 / 115000 (6.9%) | −167.6 | −165.1 | 0.19 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 360 / 11500 (3.1%) | 11629 / 115000 (10.1%) | −167.5 | −165.0 | 0.31 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 109 / 11500 (0.9%) | 7041 / 115000 (6.1%) | −167.3 | −164.8 | 0.15 |
| FOXA1 SRX371483 | MCF-7 Breast | 188 / 11500 (1.6%) | 8608 / 115000 (7.5%) | −166.8 | −164.3 | 0.22 |
| AR SRX1067070 | LHSAR Prostate | 477 / 11500 (4.1%) | 13446 / 115000 (11.7%) | −166.3 | −163.8 | 0.35 |
| ESR1 SRX371469 | MCF-7 Breast | 171 / 11500 (1.5%) | 8242 / 115000 (7.2%) | −165.3 | −162.8 | 0.21 |
| JUN SRX17561461 | LPS141 Adipocyte | 252 / 11500 (2.2%) | 9713 / 115000 (8.4%) | −164.6 | −162.1 | 0.26 |
| JUNB SRX8488073 | SUM 229PE Breast | 348 / 11500 (3.0%) | 11339 / 115000 (9.9%) | −164.5 | −162.1 | 0.31 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 152 / 11500 (1.3%) | 7836 / 115000 (6.8%) | −164.1 | −161.6 | 0.19 |
| GATA3 SRX190194 | SK-N-SH Neural | 456 / 11500 (4.0%) | 13037 / 115000 (11.3%) | −163.8 | −161.3 | 0.35 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 405 / 11500 (3.5%) | 12235 / 115000 (10.6%) | −163.8 | −161.3 | 0.33 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 645 / 11500 (5.6%) | 15849 / 115000 (13.8%) | −163.5 | −161.0 | 0.41 |
| ESR1 SRX4367193 | MCF-7 Breast | 658 / 11500 (5.7%) | 15980 / 115000 (13.9%) | −161.9 | −159.4 | 0.41 |
| SS18 SRX3468047 | Fibroblasts Others | 503 / 11500 (4.4%) | 13684 / 115000 (11.9%) | −161.7 | −159.2 | 0.37 |
| FOXA1 SRX371481 | MCF-7 Breast | 179 / 11500 (1.6%) | 8292 / 115000 (7.2%) | −161.7 | −159.2 | 0.22 |
| CEBPB SRX150632 | HeLa Uterus | 433 / 11500 (3.8%) | 12584 / 115000 (10.9%) | −160.9 | −158.5 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 157 / 11500 (1.4%) | 7839 / 115000 (6.8%) | −160.6 | −158.2 | 0.20 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 232 / 11500 (2.0%) | 9235 / 115000 (8.0%) | −160.6 | −158.1 | 0.25 |
| ESR1 SRX20282960 | MCF-7 Breast | 199 / 11500 (1.7%) | 8601 / 115000 (7.5%) | −159.4 | −157.0 | 0.23 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 229 / 11500 (2.0%) | 9147 / 115000 (8.0%) | −159.3 | −156.9 | 0.25 |
| BMI1 SRX7196721 | SF8628 Neural | 1297 / 11500 (11.3%) | 5373 / 115000 (4.7%) | −158.4 | −155.9 | 2.41 |
| FOXA1 SRX1161175 | MCF-7 Breast | 114 / 11500 (1.0%) | 6880 / 115000 (6.0%) | −157.6 | −155.2 | 0.17 |
| FOXA1 SRX100454 | T-47D Breast | 238 / 11500 (2.1%) | 9244 / 115000 (8.0%) | −157.3 | −154.9 | 0.26 |
| ESR1 SRX371471 | ZR-75-1 Breast | 191 / 11500 (1.7%) | 8386 / 115000 (7.3%) | −157.2 | −154.8 | 0.23 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 327 / 11500 (2.8%) | 10743 / 115000 (9.3%) | −156.6 | −154.2 | 0.30 |
| ESR1 SRX371479 | MCF-7 Breast | 156 / 11500 (1.4%) | 7696 / 115000 (6.7%) | −156.4 | −154.0 | 0.20 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 307 / 11500 (2.7%) | 10395 / 115000 (9.0%) | −156.2 | −153.8 | 0.30 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 145 / 11500 (1.3%) | 7468 / 115000 (6.5%) | −156.0 | −153.6 | 0.19 |
| ESR1 SRX176860 | MCF-7 Breast | 318 / 11500 (2.8%) | 10557 / 115000 (9.2%) | −155.5 | −153.1 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 205 / 11500 (1.8%) | 8590 / 115000 (7.5%) | −155.3 | −152.9 | 0.24 |
| TCF12 SRX190356 | SK-N-SH Neural | 557 / 11500 (4.8%) | 14254 / 115000 (12.4%) | −154.8 | −152.4 | 0.39 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 152 / 11500 (1.3%) | 7554 / 115000 (6.6%) | −154.1 | −151.7 | 0.20 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 224 / 11500 (1.9%) | 97 / 115000 (0.1%) | −154.0 | −151.6 | 23.09 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 155 / 11500 (1.3%) | 7563 / 115000 (6.6%) | −152.4 | −150.0 | 0.20 |
| SMARCA4 SRX5212362 | Mel270 Others | 336 / 11500 (2.9%) | 10746 / 115000 (9.3%) | −152.2 | −149.9 | 0.31 |
| RUNX1 SRX2014504 | Jurkat Blood | 1768 / 11500 (15.4%) | 8740 / 115000 (7.6%) | −152.0 | −149.7 | 2.02 |
| AR SRX1067067 | LHSAR Prostate | 333 / 11500 (2.9%) | 10690 / 115000 (9.3%) | −152.0 | −149.6 | 0.31 |
| ESR1 SRX371470 | ZR-75-1 Breast | 159 / 11500 (1.4%) | 7608 / 115000 (6.6%) | −151.3 | −149.0 | 0.21 |
| ESR1 SRX20282939 | MCF-7 Breast | 209 / 11500 (1.8%) | 8541 / 115000 (7.4%) | −151.3 | −148.9 | 0.24 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 176 / 11500 (1.5%) | 7912 / 115000 (6.9%) | −150.6 | −148.2 | 0.22 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1405 / 11500 (12.2%) | 6242 / 115000 (5.4%) | −150.3 | −147.9 | 2.25 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1422 / 11500 (12.4%) | 6362 / 115000 (5.5%) | −150.1 | −147.7 | 2.24 |
| FOXA1 SRX1161174 | MCF-7 Breast | 185 / 11500 (1.6%) | 8059 / 115000 (7.0%) | −149.9 | −147.5 | 0.23 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 390 / 11500 (3.4%) | 11538 / 115000 (10.0%) | −149.9 | −147.5 | 0.34 |
| RORC SRX5359053 | HCC70 Breast | 968 / 11500 (8.4%) | 3471 / 115000 (3.0%) | −149.1 | −146.8 | 2.79 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 606 / 11500 (5.3%) | 14761 / 115000 (12.8%) | −149.1 | −146.7 | 0.41 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 157 / 11500 (1.4%) | 7504 / 115000 (6.5%) | −149.0 | −146.7 | 0.21 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 529 / 11500 (4.6%) | 13623 / 115000 (11.8%) | −148.7 | −146.4 | 0.39 |
| SMARCA4 SRX5212366 | Mel270 Others | 255 / 11500 (2.2%) | 9256 / 115000 (8.0%) | −148.1 | −145.8 | 0.28 |
| AR SRX1067066 | LHSAR Prostate | 438 / 11500 (3.8%) | 12211 / 115000 (10.6%) | −147.7 | −145.4 | 0.36 |
| ESR1 SRX176861 | MCF-7 Breast | 333 / 11500 (2.9%) | 10539 / 115000 (9.2%) | −147.4 | −145.0 | 0.32 |
| FOXA2 SRX3230382 | Hep G2 Liver | 270 / 11500 (2.3%) | 9490 / 115000 (8.3%) | −147.3 | −144.9 | 0.28 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 244 / 11500 (2.1%) | 9041 / 115000 (7.9%) | −147.2 | −144.9 | 0.27 |
| ESR1 SRX371476 | MCF-7 Breast | 129 / 11500 (1.1%) | 6878 / 115000 (6.0%) | −146.5 | −144.2 | 0.19 |
| FOXA1 SRX11222441 | MCF-7 Breast | 128 / 11500 (1.1%) | 6857 / 115000 (6.0%) | −146.5 | −144.1 | 0.19 |
| VGLL1 SRX24602130 | BT-20 Breast | 186 / 11500 (1.6%) | 7975 / 115000 (6.9%) | −146.4 | −144.1 | 0.23 |
| ARID1A SRX5089376 | MCF-7 Breast | 147 / 11500 (1.3%) | 7232 / 115000 (6.3%) | −146.4 | −144.1 | 0.20 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1167 / 11500 (10.1%) | 4757 / 115000 (4.1%) | −146.0 | −143.6 | 2.45 |
| JUN SRX4192884 | MCF 10A Breast | 140 / 11500 (1.2%) | 7068 / 115000 (6.1%) | −145.4 | −143.1 | 0.20 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 399 / 11500 (3.5%) | 11516 / 115000 (10.0%) | −145.1 | −142.8 | 0.35 |
| MECOM SRX23677885 | HNT-34 Blood | 1299 / 11500 (11.3%) | 5636 / 115000 (4.9%) | −145.0 | −142.7 | 2.30 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 487 / 11500 (4.2%) | 997 / 115000 (0.9%) | −144.7 | −142.4 | 4.88 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 202 / 11500 (1.8%) | 8206 / 115000 (7.1%) | −144.4 | −142.1 | 0.25 |
| SMARCA4 SRX5212357 | Mel270 Others | 286 / 11500 (2.5%) | 9649 / 115000 (8.4%) | −143.9 | −141.6 | 0.30 |
| STAT3 SRX2020842 | HCC70 Breast | 364 / 11500 (3.2%) | 10922 / 115000 (9.5%) | −143.8 | −141.5 | 0.33 |
| ESR1 SRX194569 | MCF-7 Breast | 200 / 11500 (1.7%) | 8148 / 115000 (7.1%) | −143.6 | −141.3 | 0.25 |
| JUNB SRX8488074 | SUM 229PE Breast | 259 / 11500 (2.3%) | 9175 / 115000 (8.0%) | −143.3 | −141.0 | 0.28 |
| TET2 SRX2014505 | Jurkat Blood | 1900 / 11500 (16.5%) | 9924 / 115000 (8.6%) | −143.2 | −141.0 | 1.91 |
| BRD1 SRX286203 | RKO Digestive tract | 840 / 11500 (7.3%) | 2811 / 115000 (2.4%) | −143.1 | −140.8 | 2.99 |
| ESR1 SRX371467 | MCF-7 Breast | 203 / 11500 (1.8%) | 8186 / 115000 (7.1%) | −143.1 | −140.8 | 0.25 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 115 / 11500 (1.0%) | 6491 / 115000 (5.6%) | −142.8 | −140.5 | 0.18 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1313 / 11500 (11.4%) | 5775 / 115000 (5.0%) | −142.7 | −140.5 | 2.27 |
| FOXA1 SRX3931043 | MCF-7 Breast | 188 / 11500 (1.6%) | 7903 / 115000 (6.9%) | −142.7 | −140.4 | 0.24 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1316 / 11500 (11.4%) | 5796 / 115000 (5.0%) | −142.6 | −140.3 | 2.27 |
| GATA3 SRX176864 | MCF-7 Breast | 120 / 11500 (1.0%) | 6583 / 115000 (5.7%) | −142.5 | −140.2 | 0.18 |
| MECOM SRX23677897 | HNT-34 Blood | 1492 / 11500 (13.0%) | 7006 / 115000 (6.1%) | −142.4 | −140.1 | 2.13 |
| JUN SRX6582171 | GM07492 Others | 407 / 11500 (3.5%) | 11550 / 115000 (10.0%) | −142.3 | −140.1 | 0.35 |
| JUNB SRX10119386 | MCF 10A Breast | 162 / 11500 (1.4%) | 7405 / 115000 (6.4%) | −142.2 | −140.0 | 0.22 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 159 / 11500 (1.4%) | 7347 / 115000 (6.4%) | −142.2 | −139.9 | 0.22 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 138 / 11500 (1.2%) | 6934 / 115000 (6.0%) | −142.1 | −139.8 | 0.20 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 485 / 11500 (4.2%) | 12723 / 115000 (11.1%) | −141.8 | −139.5 | 0.38 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 174 / 11500 (1.5%) | 7613 / 115000 (6.6%) | −141.7 | −139.5 | 0.23 |
| MECOM SRX23677884 | HNT-34 Blood | 1275 / 11500 (11.1%) | 5540 / 115000 (4.8%) | −141.7 | −139.4 | 2.30 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1331 / 11500 (11.6%) | 5917 / 115000 (5.1%) | −141.6 | −139.3 | 2.25 |
| AR SRX9469988 | LAPC-4 Prostate | 268 / 11500 (2.3%) | 9273 / 115000 (8.1%) | −141.6 | −139.3 | 0.29 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 189 / 11500 (1.6%) | 7884 / 115000 (6.9%) | −141.6 | −139.3 | 0.24 |
| FOXA1 SRX1787653 | MCF-7 Breast | 142 / 11500 (1.2%) | 6994 / 115000 (6.1%) | −141.5 | −139.3 | 0.20 |
| ARID5B SRX3230377 | Hep G2 Liver | 544 / 11500 (4.7%) | 13574 / 115000 (11.8%) | −141.3 | −139.0 | 0.40 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 166 / 11500 (1.4%) | 7442 / 115000 (6.5%) | −141.0 | −138.7 | 0.22 |
| ESR1 SRX20282954 | MCF-7 Breast | 213 / 11500 (1.9%) | 8298 / 115000 (7.2%) | −140.9 | −138.6 | 0.26 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 634 / 11500 (5.5%) | 14857 / 115000 (12.9%) | −140.8 | −138.6 | 0.43 |
| FOXA1 SRX100506 | Hep G2 Liver | 268 / 11500 (2.3%) | 9247 / 115000 (8.0%) | −140.7 | −138.4 | 0.29 |
| MECOM SRX23677896 | HNT-34 Blood | 1538 / 11500 (13.4%) | 7365 / 115000 (6.4%) | −140.7 | −138.4 | 2.09 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 191 / 11500 (1.7%) | 7889 / 115000 (6.9%) | −140.5 | −138.3 | 0.24 |
| TP53 SRX19538272 | U2OS Bone | 426 / 11500 (3.7%) | 773 / 115000 (0.7%) | −140.5 | −138.2 | 5.51 |
| ESR1 SRX1531791 | MCF-7 Breast | 184 / 11500 (1.6%) | 7752 / 115000 (6.7%) | −140.2 | −138.0 | 0.24 |
| RORC SRX5359052 | HCC70 Breast | 974 / 11500 (8.5%) | 3648 / 115000 (3.2%) | −140.0 | −137.8 | 2.67 |
| SMARCA4 SRX5212371 | Mel270 Others | 288 / 11500 (2.5%) | 9563 / 115000 (8.3%) | −140.0 | −137.8 | 0.30 |
| BRPF3 SRX796085 | RKO Digestive tract | 776 / 11500 (6.7%) | 2492 / 115000 (2.2%) | −139.9 | −137.7 | 3.11 |
| FOXA1 SRX11222442 | MCF-7 Breast | 111 / 11500 (1.0%) | 6325 / 115000 (5.5%) | −139.8 | −137.6 | 0.18 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 178 / 11500 (1.5%) | 7627 / 115000 (6.6%) | −139.7 | −137.5 | 0.23 |
| FOXA1 SRX371480 | MCF-7 Breast | 116 / 11500 (1.0%) | 6422 / 115000 (5.6%) | −139.6 | −137.4 | 0.18 |
| EP300 SRX2194265 | SUM 159PT Breast | 326 / 11500 (2.8%) | 10166 / 115000 (8.8%) | −139.4 | −137.2 | 0.32 |
| ESR1 SRX194572 | MCF-7 Breast | 107 / 11500 (0.9%) | 6227 / 115000 (5.4%) | −139.3 | −137.0 | 0.17 |
| ESR1 SRX20282972 | MCF-7 Breast | 223 / 11500 (1.9%) | 8424 / 115000 (7.3%) | −139.1 | −136.9 | 0.26 |
| FOXA1 SRX3923514 | MCF-7 Breast | 197 / 11500 (1.7%) | 7954 / 115000 (6.9%) | −139.1 | −136.9 | 0.25 |
| EP300 SRX2671813 | Fibroblasts Others | 150 / 11500 (1.3%) | 7069 / 115000 (6.1%) | −138.7 | −136.5 | 0.21 |
| ESR1 SRX371468 | MCF-7 Breast | 111 / 11500 (1.0%) | 6285 / 115000 (5.5%) | −138.4 | −136.2 | 0.18 |
| RAC1 SRX10365541 | MCF-7 Breast | 81 / 11500 (0.7%) | 5638 / 115000 (4.9%) | −138.1 | −135.9 | 0.14 |
| FOXA1 SRX11222437 | MCF-7 Breast | 127 / 11500 (1.1%) | 6602 / 115000 (5.7%) | −138.1 | −135.9 | 0.19 |
| KAT7 SRX101303 | RKO Digestive tract | 944 / 11500 (8.2%) | 3493 / 115000 (3.0%) | −138.1 | −135.9 | 2.70 |
| GATA3 SRX5057632 | MCF-7 Breast | 110 / 11500 (1.0%) | 6254 / 115000 (5.4%) | −138.0 | −135.8 | 0.18 |
| MethylCap SRX014767 | NB-4 Blood | 1266 / 11500 (11.0%) | 5555 / 115000 (4.8%) | −138.0 | −135.8 | 2.28 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 288 / 11500 (2.5%) | 9490 / 115000 (8.3%) | −137.8 | −135.7 | 0.30 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 846 / 11500 (7.4%) | 2919 / 115000 (2.5%) | −137.8 | −135.6 | 2.90 |
| FOXA1 SRX3931055 | MCF-7 Breast | 155 / 11500 (1.3%) | 7123 / 115000 (6.2%) | −137.3 | −135.1 | 0.22 |
| JUNB SRX4192882 | MCF 10A Breast | 143 / 11500 (1.2%) | 6892 / 115000 (6.0%) | −137.1 | −135.0 | 0.21 |
| ARID1A SRX5089379 | MCF-7 Breast | 189 / 11500 (1.6%) | 7753 / 115000 (6.7%) | −137.1 | −134.9 | 0.24 |
| FOSL2 SRX190296 | SK-N-SH Neural | 272 / 11500 (2.4%) | 9193 / 115000 (8.0%) | −136.9 | −134.7 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 325 / 11500 (2.8%) | 10064 / 115000 (8.8%) | −136.8 | −134.7 | 0.32 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 213 / 11500 (1.9%) | 8167 / 115000 (7.1%) | −136.6 | −134.5 | 0.26 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 172 / 11500 (1.5%) | 7422 / 115000 (6.5%) | −136.5 | −134.3 | 0.23 |
| RAC1 SRX10365543 | MCF-7 Breast | 84 / 11500 (0.7%) | 5657 / 115000 (4.9%) | −136.4 | −134.3 | 0.15 |
| NR3C1 SRX17639412 | A549 Lung | 221 / 11500 (1.9%) | 8288 / 115000 (7.2%) | −135.9 | −133.8 | 0.27 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 591 / 11500 (5.1%) | 1559 / 115000 (1.4%) | −135.8 | −133.7 | 3.79 |
| ESR1 SRX2943591 | MCF-7 Breast | 126 / 11500 (1.1%) | 6512 / 115000 (5.7%) | −135.7 | −133.5 | 0.19 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 276 / 11500 (2.4%) | 9220 / 115000 (8.0%) | −135.6 | −133.5 | 0.30 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 181 / 11500 (1.6%) | 7556 / 115000 (6.6%) | −135.5 | −133.4 | 0.24 |
| FOXA1 SRX1161203 | T-47D Breast | 128 / 11500 (1.1%) | 6535 / 115000 (5.7%) | −135.1 | −133.0 | 0.20 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 177 / 11500 (1.5%) | 7468 / 115000 (6.5%) | −135.0 | −132.9 | 0.24 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 318 / 11500 (2.8%) | 9889 / 115000 (8.6%) | −134.9 | −132.7 | 0.32 |
| PBX3 SRX190343 | SK-N-SH Neural | 456 / 11500 (4.0%) | 12033 / 115000 (10.5%) | −134.7 | −132.5 | 0.38 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 373 / 11500 (3.2%) | 10752 / 115000 (9.3%) | −134.5 | −132.4 | 0.35 |
| FOXA1 SRX6878603 | LNCAP Prostate | 223 / 11500 (1.9%) | 8270 / 115000 (7.2%) | −134.2 | −132.1 | 0.27 |
| ESR1 SRX371475 | BT-474 Breast | 81 / 11500 (0.7%) | 5531 / 115000 (4.8%) | −134.1 | −132.0 | 0.15 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 477 / 11500 (4.1%) | 1036 / 115000 (0.9%) | −134.1 | −131.9 | 4.60 |
| FOXL2 SRX6957431 | KGN Gonad | 505 / 11500 (4.4%) | 12728 / 115000 (11.1%) | −133.8 | −131.6 | 0.40 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1237 / 11500 (10.8%) | 5449 / 115000 (4.7%) | −133.5 | −131.3 | 2.27 |
| ESR1 SRX371477 | MCF-7 Breast | 82 / 11500 (0.7%) | 5525 / 115000 (4.8%) | −133.2 | −131.0 | 0.15 |
| TEAD1 SRX3401272 | MCF-7 Breast | 135 / 11500 (1.2%) | 6615 / 115000 (5.8%) | −133.1 | −131.0 | 0.20 |
| JUNB SRX8488089 | SUM 229PE Breast | 194 / 11500 (1.7%) | 7716 / 115000 (6.7%) | −133.0 | −130.9 | 0.25 |
| JUND SRX190357 | SK-N-SH Neural | 258 / 11500 (2.2%) | 8831 / 115000 (7.7%) | −132.9 | −130.8 | 0.29 |
| AR SRX10820653 | LNCAP Prostate | 238 / 11500 (2.1%) | 182 / 115000 (0.2%) | −132.8 | −130.7 | 13.08 |
| ESR1 SRX10365536 | MCF-7 Breast | 89 / 11500 (0.8%) | 5666 / 115000 (4.9%) | −132.8 | −130.6 | 0.16 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 210 / 11500 (1.8%) | 7995 / 115000 (7.0%) | −132.7 | −130.6 | 0.26 |
| FOXA1 SRX3931054 | MCF-7 Breast | 184 / 11500 (1.6%) | 7528 / 115000 (6.5%) | −132.7 | −130.6 | 0.24 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 188 / 11500 (1.6%) | 7598 / 115000 (6.6%) | −132.6 | −130.5 | 0.25 |
| FOXA1 SRX15430999 | T-47D Breast | 230 / 11500 (2.0%) | 8339 / 115000 (7.3%) | −132.6 | −130.5 | 0.28 |
| YAP1 SRX10119364 | MCF 10A Breast | 158 / 11500 (1.4%) | 7042 / 115000 (6.1%) | −132.5 | −130.4 | 0.22 |
| NKX2-1 SRX2164786 | A549 Lung | 352 / 11500 (3.1%) | 10350 / 115000 (9.0%) | −132.4 | −130.3 | 0.34 |
| EP300 SRX2194266 | SUM 159PT Breast | 376 / 11500 (3.3%) | 10719 / 115000 (9.3%) | −132.2 | −130.1 | 0.35 |
| PRRX1 SRX15235713 | Hs 578T Breast | 250 / 11500 (2.2%) | 8663 / 115000 (7.5%) | −132.0 | −129.9 | 0.29 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 377 / 11500 (3.3%) | 10710 / 115000 (9.3%) | −131.5 | −129.4 | 0.35 |
| FOXA1 SRX028634 | MCF-7 Breast | 79 / 11500 (0.7%) | 5404 / 115000 (4.7%) | −131.3 | −129.1 | 0.15 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1462 / 11500 (12.7%) | 7049 / 115000 (6.1%) | −131.1 | −129.0 | 2.07 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 184 / 11500 (1.6%) | 7467 / 115000 (6.5%) | −130.8 | −128.7 | 0.25 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 371 / 11500 (3.2%) | 10585 / 115000 (9.2%) | −130.7 | −128.5 | 0.35 |
| CEBPA SRX2630241 | Hep G2 Liver | 261 / 11500 (2.3%) | 8801 / 115000 (7.7%) | −130.5 | −128.4 | 0.30 |
| WWTR1 SRX10119367 | MCF 10A Breast | 243 / 11500 (2.1%) | 8496 / 115000 (7.4%) | −130.5 | −128.4 | 0.29 |
| STAT5B SRX831881 | CD8+ T cells Blood | 208 / 11500 (1.8%) | 119 / 115000 (0.1%) | −130.4 | −128.3 | 17.48 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 272 / 11500 (2.4%) | 8984 / 115000 (7.8%) | −130.4 | −128.3 | 0.30 |
| ESR1 SRX20282940 | MCF-7 Breast | 226 / 11500 (2.0%) | 8197 / 115000 (7.1%) | −130.2 | −128.1 | 0.28 |
| TLE3 SRX4815192 | MCF-7 Breast | 176 / 11500 (1.5%) | 7307 / 115000 (6.4%) | −130.2 | −128.1 | 0.24 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 216 / 11500 (1.9%) | 8022 / 115000 (7.0%) | −130.2 | −128.1 | 0.27 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 326 / 11500 (2.8%) | 9851 / 115000 (8.6%) | −130.0 | −127.9 | 0.33 |
| FOXA2 SRX100448 | Hep G2 Liver | 233 / 11500 (2.0%) | 8300 / 115000 (7.2%) | −129.7 | −127.6 | 0.28 |
| GATA3 SRX6712581 | MCF-7 Breast | 164 / 11500 (1.4%) | 7055 / 115000 (6.1%) | −129.3 | −127.2 | 0.23 |
| ESR1 SRX20282955 | MCF-7 Breast | 220 / 11500 (1.9%) | 8057 / 115000 (7.0%) | −129.1 | −127.1 | 0.27 |
| ESR1 SRX20282973 | MCF-7 Breast | 256 / 11500 (2.2%) | 8672 / 115000 (7.5%) | −129.1 | −127.0 | 0.30 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 411 / 11500 (3.6%) | 11133 / 115000 (9.7%) | −128.6 | −126.5 | 0.37 |
| RELA SRX5938177 | FaDu Others | 184 / 11500 (1.6%) | 7394 / 115000 (6.4%) | −128.3 | −126.3 | 0.25 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 195 / 11500 (1.7%) | 7583 / 115000 (6.6%) | −128.0 | −125.9 | 0.26 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 160 / 11500 (1.4%) | 6935 / 115000 (6.0%) | −127.7 | −125.7 | 0.23 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 612 / 11500 (5.3%) | 14042 / 115000 (12.2%) | −127.6 | −125.5 | 0.44 |
| FOXA1 SRX100477 | Hep G2 Liver | 246 / 11500 (2.1%) | 8453 / 115000 (7.4%) | −127.4 | −125.4 | 0.29 |
| JUN SRX6582172 | Fibroblasts Others | 288 / 11500 (2.5%) | 9132 / 115000 (7.9%) | −126.9 | −124.8 | 0.32 |
| FOXA1 SRX9604647 | LNCAP Prostate | 335 / 11500 (2.9%) | 9892 / 115000 (8.6%) | −126.9 | −124.8 | 0.34 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1333 / 11500 (11.6%) | 6244 / 115000 (5.4%) | −126.8 | −124.7 | 2.13 |
| SOX13 SRX2636248 | Hep G2 Liver | 299 / 11500 (2.6%) | 9308 / 115000 (8.1%) | −126.8 | −124.7 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 108 / 11500 (0.9%) | 5895 / 115000 (5.1%) | −126.8 | −124.7 | 0.18 |
| NR2F2 SRX190293 | MCF-7 Breast | 224 / 11500 (1.9%) | 8055 / 115000 (7.0%) | −126.8 | −124.7 | 0.28 |
| NR3C1 SRX2609664 | HASM2 Lung | 305 / 11500 (2.7%) | 9405 / 115000 (8.2%) | −126.7 | −124.6 | 0.32 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 697 / 11500 (6.1%) | 15183 / 115000 (13.2%) | −126.3 | −124.2 | 0.46 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 437 / 11500 (3.8%) | 11438 / 115000 (9.9%) | −126.0 | −124.0 | 0.38 |
| JUNB SRX10119383 | MCF 10A Breast | 132 / 11500 (1.1%) | 6350 / 115000 (5.5%) | −125.9 | −123.8 | 0.21 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 139 / 11500 (1.2%) | 6482 / 115000 (5.6%) | −125.8 | −123.8 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 82 / 11500 (0.7%) | 5324 / 115000 (4.6%) | −125.8 | −123.7 | 0.15 |
| ESR1 SRX2881000 | MCF-7 Breast | 179 / 11500 (1.6%) | 7220 / 115000 (6.3%) | −125.6 | −123.6 | 0.25 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 154 / 11500 (1.3%) | 6759 / 115000 (5.9%) | −125.6 | −123.5 | 0.23 |
| ESR1 SRX20282946 | MCF-7 Breast | 111 / 11500 (1.0%) | 5923 / 115000 (5.2%) | −125.6 | −123.5 | 0.19 |
| FOS SRX070879 | HUVEC Cardiovascular | 222 / 11500 (1.9%) | 7980 / 115000 (6.9%) | −125.5 | −123.5 | 0.28 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 351 / 11500 (3.1%) | 10097 / 115000 (8.8%) | −125.5 | −123.5 | 0.35 |
| FOXA1 SRX219284 | LNCAP Prostate | 299 / 11500 (2.6%) | 9265 / 115000 (8.1%) | −125.5 | −123.4 | 0.32 |
| DAXX SRX1021630 | PC-3 Prostate | 211 / 11500 (1.8%) | 7775 / 115000 (6.8%) | −125.1 | −123.1 | 0.27 |
| JUND SRX150408 | HeLa Uterus | 178 / 11500 (1.5%) | 7186 / 115000 (6.2%) | −125.1 | −123.0 | 0.25 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 314 / 11500 (2.7%) | 9494 / 115000 (8.3%) | −125.1 | −123.0 | 0.33 |
| ESR1 SRX10365535 | MCF-7 Breast | 166 / 11500 (1.4%) | 6965 / 115000 (6.1%) | −125.0 | −122.9 | 0.24 |
| FOXA1 SRX3923516 | MCF-7 Breast | 143 / 11500 (1.2%) | 6530 / 115000 (5.7%) | −124.8 | −122.8 | 0.22 |
| BRPF3 SRX796086 | RKO Digestive tract | 987 / 11500 (8.6%) | 3986 / 115000 (3.5%) | −124.4 | −122.3 | 2.48 |
| FOXA1 SRX5323829 | T-47D Breast | 102 / 11500 (0.9%) | 5704 / 115000 (5.0%) | −124.4 | −122.3 | 0.18 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 292 / 11500 (2.5%) | 9114 / 115000 (7.9%) | −124.3 | −122.3 | 0.32 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 326 / 11500 (2.8%) | 9659 / 115000 (8.4%) | −124.3 | −122.3 | 0.34 |
| FOXA1 SRX1447317 | MCF-7 Breast | 127 / 11500 (1.1%) | 6203 / 115000 (5.4%) | −124.2 | −122.2 | 0.20 |
| CEBPA SRX4705113 | MOLM-13 Blood | 529 / 11500 (4.6%) | 12729 / 115000 (11.1%) | −124.2 | −122.2 | 0.42 |
| AR SRX9109110 | MDA-MB-453 Breast | 437 / 11500 (3.8%) | 11371 / 115000 (9.9%) | −124.2 | −122.1 | 0.38 |
| FOXA1 SRX11222438 | MCF-7 Breast | 98 / 11500 (0.9%) | 5612 / 115000 (4.9%) | −124.0 | −121.9 | 0.17 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 170 / 11500 (1.5%) | 7007 / 115000 (6.1%) | −124.0 | −121.9 | 0.24 |
| FOXA1 SRX5323843 | MCF-7 Breast | 95 / 11500 (0.8%) | 5538 / 115000 (4.8%) | −123.6 | −121.6 | 0.17 |
| BRPF3 SRX796084 | RKO Digestive tract | 1019 / 11500 (8.9%) | 4209 / 115000 (3.7%) | −123.4 | −121.4 | 2.42 |
| Epitope tags SRX2255894 | 293 Kidney | 965 / 11500 (8.4%) | 3867 / 115000 (3.4%) | −123.3 | −121.3 | 2.50 |
| ESR1 SRX2943589 | MCF-7 Breast | 92 / 11500 (0.8%) | 5465 / 115000 (4.8%) | −123.2 | −121.2 | 0.17 |
| FOXA1 SRX3923518 | MCF-7 Breast | 137 / 11500 (1.2%) | 6364 / 115000 (5.5%) | −123.1 | −121.0 | 0.22 |
| FOXA1 SRX3923517 | MCF-7 Breast | 141 / 11500 (1.2%) | 6437 / 115000 (5.6%) | −123.0 | −121.0 | 0.22 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 172 / 11500 (1.5%) | 7012 / 115000 (6.1%) | −122.9 | −120.9 | 0.25 |
| EP300 SRX150579 | HeLa Uterus | 125 / 11500 (1.1%) | 6123 / 115000 (5.3%) | −122.9 | −120.9 | 0.20 |
| GATAD2A SRX2636506 | Hep G2 Liver | 287 / 11500 (2.5%) | 8983 / 115000 (7.8%) | −122.8 | −120.8 | 0.32 |
| FOXA1 SRX3931033 | MCF-7 Breast | 122 / 11500 (1.1%) | 6055 / 115000 (5.3%) | −122.6 | −120.6 | 0.20 |
| JUN SRX6582163 | BJ-5ta Epidermis | 277 / 11500 (2.4%) | 8807 / 115000 (7.7%) | −122.6 | −120.5 | 0.31 |
| STAT3 SRX150479 | MCF 10A Breast | 197 / 11500 (1.7%) | 7439 / 115000 (6.5%) | −122.2 | −120.2 | 0.26 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 411 / 11500 (3.6%) | 10903 / 115000 (9.5%) | −122.2 | −120.2 | 0.38 |
| FOXA1 SRX1787655 | MCF-7 Breast | 91 / 11500 (0.8%) | 5412 / 115000 (4.7%) | −122.1 | −120.1 | 0.17 |
| STAT3 SRX150630 | MCF 10A Breast | 196 / 11500 (1.7%) | 7407 / 115000 (6.4%) | −121.8 | −119.8 | 0.26 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 346 / 11500 (3.0%) | 9885 / 115000 (8.6%) | −121.6 | −119.6 | 0.35 |
| FOXA1 SRX1961157 | T-47D Breast | 243 / 11500 (2.1%) | 8207 / 115000 (7.1%) | −121.5 | −119.5 | 0.30 |
| FOSL2 SRX190204 | A549 Lung | 210 / 11500 (1.8%) | 7643 / 115000 (6.6%) | −121.5 | −119.5 | 0.27 |
| FOXA1 SRX1787651 | MCF-7 Breast | 106 / 11500 (0.9%) | 5704 / 115000 (5.0%) | −121.5 | −119.5 | 0.19 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 299 / 11500 (2.6%) | 9122 / 115000 (7.9%) | −121.3 | −119.3 | 0.33 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 374 / 11500 (3.3%) | 692 / 115000 (0.6%) | −121.3 | −119.3 | 5.40 |
| EP300 SRX176885 | MCF-7 Breast | 98 / 11500 (0.9%) | 5516 / 115000 (4.8%) | −120.6 | −118.6 | 0.18 |
| AR SRX9109113 | MDA-MB-453 Breast | 455 / 11500 (4.0%) | 11505 / 115000 (10.0%) | −120.6 | −118.6 | 0.40 |
| FOXA1 SRX1961158 | T-47D Breast | 217 / 11500 (1.9%) | 7733 / 115000 (6.7%) | −120.4 | −118.4 | 0.28 |
| ESR1 SRX2881002 | MCF-7 Breast | 206 / 11500 (1.8%) | 7536 / 115000 (6.6%) | −120.3 | −118.3 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 86 / 11500 (0.7%) | 5254 / 115000 (4.6%) | −120.3 | −118.3 | 0.16 |
| GATA3 SRX5457550 | MCF-7 Breast | 241 / 11500 (2.1%) | 8132 / 115000 (7.1%) | −120.2 | −118.2 | 0.30 |
| ESR1 SRX3110725 | MCF-7 Breast | 190 / 11500 (1.7%) | 7253 / 115000 (6.3%) | −120.2 | −118.2 | 0.26 |
| FOXA1 SRX028635 | MCF-7 Breast | 93 / 11500 (0.8%) | 5395 / 115000 (4.7%) | −120.0 | −118.1 | 0.17 |
| FOXA1 SRX5323830 | T-47D Breast | 115 / 11500 (1.0%) | 5847 / 115000 (5.1%) | −120.0 | −118.1 | 0.20 |
| ARID1A SRX5089385 | MCF-7 Breast | 151 / 11500 (1.3%) | 6539 / 115000 (5.7%) | −120.0 | −118.0 | 0.23 |
| GRHL3 SRX2582162 | NHEK Epidermis | 770 / 11500 (6.7%) | 2729 / 115000 (2.4%) | −120.0 | −118.0 | 2.82 |
| FOXA1 SRX190181 | A549 Lung | 150 / 11500 (1.3%) | 6517 / 115000 (5.7%) | −119.9 | −118.0 | 0.23 |
| PGR SRX1012655 | MCF-7 Breast | 125 / 11500 (1.1%) | 6036 / 115000 (5.2%) | −119.9 | −117.9 | 0.21 |
| FOXA1 SRX3923519 | MCF-7 Breast | 122 / 11500 (1.1%) | 5979 / 115000 (5.2%) | −119.9 | −117.9 | 0.20 |
| FOXA1 SRX190282 | A549 Lung | 143 / 11500 (1.2%) | 6385 / 115000 (5.6%) | −119.9 | −117.9 | 0.22 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 137 / 11500 (1.2%) | 6268 / 115000 (5.5%) | −119.8 | −117.8 | 0.22 |
| STAT3 SRX150536 | MCF 10A Breast | 246 / 11500 (2.1%) | 8202 / 115000 (7.1%) | −119.8 | −117.8 | 0.30 |
| ARID1A SRX5089391 | MCF-7 Breast | 103 / 11500 (0.9%) | 5596 / 115000 (4.9%) | −119.8 | −117.8 | 0.18 |
| ARID5B SRX10475139 | Hep G2 Liver | 243 / 11500 (2.1%) | 8151 / 115000 (7.1%) | −119.7 | −117.8 | 0.30 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 204 / 11500 (1.8%) | 7483 / 115000 (6.5%) | −119.7 | −117.7 | 0.27 |
| ESR1 SRX4367192 | MCF-7 Breast | 480 / 11500 (4.2%) | 11827 / 115000 (10.3%) | −119.3 | −117.3 | 0.41 |
| ESR1 SRX20282953 | MCF-7 Breast | 174 / 11500 (1.5%) | 6934 / 115000 (6.0%) | −119.2 | −117.2 | 0.25 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 414 / 11500 (3.6%) | 10840 / 115000 (9.4%) | −119.2 | −117.2 | 0.38 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 380 / 11500 (3.3%) | 10324 / 115000 (9.0%) | −119.1 | −117.2 | 0.37 |
| PROX1 SRX3230397 | Hep G2 Liver | 151 / 11500 (1.3%) | 6509 / 115000 (5.7%) | −119.1 | −117.1 | 0.23 |
| SP1 SRX190358 | HCT 116 Digestive tract | 360 / 11500 (3.1%) | 10012 / 115000 (8.7%) | −119.1 | −117.1 | 0.36 |
| WWTR1 SRX10119378 | MCF 10A Breast | 238 / 11500 (2.1%) | 8044 / 115000 (7.0%) | −119.0 | −117.0 | 0.30 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 157 / 11500 (1.4%) | 6606 / 115000 (5.7%) | −118.7 | −116.7 | 0.24 |
| NR3C1 SRX10976921 | A549 Lung | 148 / 11500 (1.3%) | 6439 / 115000 (5.6%) | −118.6 | −116.6 | 0.23 |
| EP300 SRX100540 | SK-N-SH Neural | 333 / 11500 (2.9%) | 9570 / 115000 (8.3%) | −118.5 | −116.5 | 0.35 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 195 / 11500 (1.7%) | 7286 / 115000 (6.3%) | −118.5 | −116.5 | 0.27 |
| AR SRX10820651 | LNCAP Prostate | 248 / 11500 (2.2%) | 260 / 115000 (0.2%) | −118.4 | −116.5 | 9.54 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 186 / 11500 (1.6%) | 7123 / 115000 (6.2%) | −118.3 | −116.4 | 0.26 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 290 / 11500 (2.5%) | 8880 / 115000 (7.7%) | −118.3 | −116.3 | 0.33 |
| ARID5B SRX10475138 | Hep G2 Liver | 392 / 11500 (3.4%) | 10471 / 115000 (9.1%) | −118.2 | −116.2 | 0.37 |
| FOS SRX3322636 | MCF-7 Breast | 132 / 11500 (1.1%) | 6121 / 115000 (5.3%) | −118.1 | −116.2 | 0.22 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 124 / 11500 (1.1%) | 5968 / 115000 (5.2%) | −118.1 | −116.2 | 0.21 |
| JUNB SRX10119384 | MCF 10A Breast | 123 / 11500 (1.1%) | 5947 / 115000 (5.2%) | −118.1 | −116.1 | 0.21 |
| FOXA1 SRX1161205 | T-47D Breast | 102 / 11500 (0.9%) | 5527 / 115000 (4.8%) | −118.0 | −116.0 | 0.18 |
| GATAD2A SRX2636507 | Hep G2 Liver | 244 / 11500 (2.1%) | 8113 / 115000 (7.1%) | −118.0 | −116.0 | 0.30 |
| ESR1 SRX20282971 | MCF-7 Breast | 221 / 11500 (1.9%) | 7723 / 115000 (6.7%) | −118.0 | −116.0 | 0.29 |
| ESR1 SRX10365533 | MCF-7 Breast | 90 / 11500 (0.8%) | 5273 / 115000 (4.6%) | −117.9 | −116.0 | 0.17 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 307 / 11500 (2.7%) | 9136 / 115000 (7.9%) | −117.9 | −115.9 | 0.34 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 181 / 11500 (1.6%) | 7017 / 115000 (6.1%) | −117.9 | −115.9 | 0.26 |
| FOS SRX150664 | HUVEC Cardiovascular | 302 / 11500 (2.6%) | 9052 / 115000 (7.9%) | −117.8 | −115.8 | 0.33 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 237 / 11500 (2.1%) | 7986 / 115000 (6.9%) | −117.8 | −115.8 | 0.30 |
| ESR1 SRX1012632 | MCF-7 Breast | 94 / 11500 (0.8%) | 5352 / 115000 (4.7%) | −117.6 | −115.7 | 0.18 |
| SSRP1 SRX3436567 | HT-1080 Bone | 303 / 11500 (2.6%) | 444 / 115000 (0.4%) | −117.5 | −115.5 | 6.82 |
| AR SRX1067068 | LHSAR Prostate | 274 / 11500 (2.4%) | 8583 / 115000 (7.5%) | −117.2 | −115.3 | 0.32 |
| SP1 SRX190269 | A549 Lung | 342 / 11500 (3.0%) | 9666 / 115000 (8.4%) | −117.1 | −115.2 | 0.35 |
| HMG20A SRX2630163 | Hep G2 Liver | 112 / 11500 (1.0%) | 5701 / 115000 (5.0%) | −117.1 | −115.2 | 0.20 |
| JUN SRX2355072 | HAEC Cardiovascular | 299 / 11500 (2.6%) | 8985 / 115000 (7.8%) | −117.1 | −115.1 | 0.33 |
| ZEB1 SRX13298925 | MCF-7 Breast | 121 / 11500 (1.1%) | 5867 / 115000 (5.1%) | −116.7 | −114.8 | 0.21 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 179 / 11500 (1.6%) | 6943 / 115000 (6.0%) | −116.6 | −114.7 | 0.26 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 132 / 11500 (1.1%) | 6076 / 115000 (5.3%) | −116.6 | −114.7 | 0.22 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 463 / 11500 (4.0%) | 11476 / 115000 (10.0%) | −116.6 | −114.6 | 0.40 |
| ESR1 SRX20282938 | MCF-7 Breast | 176 / 11500 (1.5%) | 6887 / 115000 (6.0%) | −116.5 | −114.6 | 0.26 |
| ESR1 SRX5323873 | MCF-7 Breast | 286 / 11500 (2.5%) | 8748 / 115000 (7.6%) | −116.4 | −114.5 | 0.33 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 338 / 11500 (2.9%) | 9575 / 115000 (8.3%) | −116.3 | −114.4 | 0.35 |
| TEAD3 SRX2636153 | Hep G2 Liver | 585 / 11500 (5.1%) | 13224 / 115000 (11.5%) | −116.3 | −114.4 | 0.44 |
| FOXA1 SRX3931056 | MCF-7 Breast | 119 / 11500 (1.0%) | 5813 / 115000 (5.1%) | −116.2 | −114.2 | 0.20 |
| FOXA1 SRX1161207 | T-47D Breast | 74 / 11500 (0.6%) | 4880 / 115000 (4.2%) | −116.2 | −114.2 | 0.15 |
| FOXA1 SRX3923515 | MCF-7 Breast | 113 / 11500 (1.0%) | 5688 / 115000 (4.9%) | −116.1 | −114.1 | 0.20 |
| MethylCap SRX014766 | NB-4 Blood | 1093 / 11500 (9.5%) | 4838 / 115000 (4.2%) | −116.0 | −114.0 | 2.26 |
| FOXA1 SRX6878604 | LNCAP Prostate | 179 / 11500 (1.6%) | 6913 / 115000 (6.0%) | −115.6 | −113.7 | 0.26 |
| FOXA1 SRX9604645 | LNCAP Prostate | 333 / 11500 (2.9%) | 9459 / 115000 (8.2%) | −115.2 | −113.3 | 0.35 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 139 / 11500 (1.2%) | 6164 / 115000 (5.4%) | −115.0 | −113.1 | 0.23 |
| TP53 SRX396254 | Fibroblasts Others | 610 / 11500 (5.3%) | 1889 / 115000 (1.6%) | −115.0 | −113.1 | 3.23 |
| ESR1 SRX4451213 | MCF-7 Breast | 230 / 11500 (2.0%) | 7775 / 115000 (6.8%) | −114.9 | −113.0 | 0.30 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 143 / 11500 (1.2%) | 6231 / 115000 (5.4%) | −114.9 | −113.0 | 0.23 |
| ARID1A SRX5089382 | MCF-7 Breast | 147 / 11500 (1.3%) | 6307 / 115000 (5.5%) | −114.9 | −112.9 | 0.23 |
| JUN SRX2355073 | HAEC Cardiovascular | 291 / 11500 (2.5%) | 8775 / 115000 (7.6%) | −114.8 | −112.9 | 0.33 |
| ESR1 SRX10365532 | MCF-7 Breast | 109 / 11500 (0.9%) | 5572 / 115000 (4.8%) | −114.8 | −112.9 | 0.20 |
| GATA3 SRX100559 | T-47D Breast | 251 / 11500 (2.2%) | 8118 / 115000 (7.1%) | −114.7 | −112.8 | 0.31 |
| FOXL2 SRX6957477 | KGN Gonad | 238 / 11500 (2.1%) | 7892 / 115000 (6.9%) | −114.3 | −112.4 | 0.30 |
| EP300 SRX1012648 | MCF-7 Breast | 93 / 11500 (0.8%) | 5219 / 115000 (4.5%) | −113.8 | −111.9 | 0.18 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 99 / 11500 (0.9%) | 5346 / 115000 (4.6%) | −113.8 | −111.9 | 0.19 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 440 / 11500 (3.8%) | 11029 / 115000 (9.6%) | −113.6 | −111.7 | 0.40 |
| RNF2 SRX18954719 | SCC-25 Others | 320 / 11500 (2.8%) | 9198 / 115000 (8.0%) | −113.6 | −111.7 | 0.35 |
| FOXA1 SRX1447316 | MCF-7 Breast | 83 / 11500 (0.7%) | 4989 / 115000 (4.3%) | −113.1 | −111.1 | 0.17 |
| VGLL1 SRX18013277 | FULVR Breast | 79 / 11500 (0.7%) | 4903 / 115000 (4.3%) | −113.0 | −111.1 | 0.16 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 143 / 11500 (1.2%) | 6171 / 115000 (5.4%) | −112.7 | −110.8 | 0.23 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 238 / 11500 (2.1%) | 7840 / 115000 (6.8%) | −112.7 | −110.8 | 0.30 |
| ESR1 SRX330067 | MCF-7 Breast | 207 / 11500 (1.8%) | 7310 / 115000 (6.4%) | −112.7 | −110.8 | 0.28 |
| FOXA1 SRX219285 | LNCAP Prostate | 216 / 11500 (1.9%) | 7466 / 115000 (6.5%) | −112.6 | −110.7 | 0.29 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 145 / 11500 (1.3%) | 6201 / 115000 (5.4%) | −112.6 | −110.7 | 0.23 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 119 / 11500 (1.0%) | 5701 / 115000 (5.0%) | −112.5 | −110.6 | 0.21 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 199 / 11500 (1.7%) | 7164 / 115000 (6.2%) | −112.4 | −110.5 | 0.28 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 189 / 11500 (1.6%) | 6982 / 115000 (6.1%) | −112.1 | −110.2 | 0.27 |
| NR3C1 SRX2609662 | HASM2 Lung | 281 / 11500 (2.4%) | 8526 / 115000 (7.4%) | −112.1 | −110.2 | 0.33 |
| ESR1 SRX8537722 | MCF-7 Breast | 213 / 11500 (1.9%) | 7392 / 115000 (6.4%) | −112.0 | −110.1 | 0.29 |
| FOXA1 SRX13814018 | 5637 Others | 139 / 11500 (1.2%) | 6071 / 115000 (5.3%) | −112.0 | −110.1 | 0.23 |
| YAP1 SRX1038945 | IMR-90 Lung | 166 / 11500 (1.4%) | 6564 / 115000 (5.7%) | −111.9 | −110.0 | 0.25 |
| NFIL3 SRX2630334 | Hep G2 Liver | 179 / 11500 (1.6%) | 6798 / 115000 (5.9%) | −111.9 | −110.0 | 0.26 |
| CEBPB SRX190345 | MCF-7 Breast | 176 / 11500 (1.5%) | 6732 / 115000 (5.9%) | −111.5 | −109.6 | 0.26 |
| FOXA1 SRX6860635 | T-47D Breast | 171 / 11500 (1.5%) | 6640 / 115000 (5.8%) | −111.5 | −109.6 | 0.26 |
| FOXA1 SRX3931032 | MCF-7 Breast | 122 / 11500 (1.1%) | 5731 / 115000 (5.0%) | −111.4 | −109.5 | 0.21 |
| JUN SRX6582164 | BJ-5ta Epidermis | 299 / 11500 (2.6%) | 8785 / 115000 (7.6%) | −111.3 | −109.4 | 0.34 |
| ESR1 SRX5323871 | MCF-7 Breast | 259 / 11500 (2.3%) | 8130 / 115000 (7.1%) | −111.0 | −109.1 | 0.32 |
| ESR1 SRX330070 | MCF-7 Breast | 109 / 11500 (0.9%) | 5461 / 115000 (4.7%) | −110.9 | −109.0 | 0.20 |
| NR3C1 SRX2609665 | HASM2 Lung | 260 / 11500 (2.3%) | 8139 / 115000 (7.1%) | −110.9 | −109.0 | 0.32 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 221 / 11500 (1.9%) | 7489 / 115000 (6.5%) | −110.8 | −108.9 | 0.30 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 170 / 11500 (1.5%) | 88 / 115000 (0.1%) | −110.5 | −108.6 | 19.32 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 273 / 11500 (2.4%) | 8337 / 115000 (7.2%) | −110.4 | −108.5 | 0.33 |
| FOXA1 SRX2642368 | VCaP Prostate | 297 / 11500 (2.6%) | 8721 / 115000 (7.6%) | −110.4 | −108.5 | 0.34 |
| FOXA1 SRX2017929 | LNCAP Prostate | 316 / 11500 (2.7%) | 9020 / 115000 (7.8%) | −110.3 | −108.4 | 0.35 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 859 / 11500 (7.5%) | 3425 / 115000 (3.0%) | −110.3 | −108.4 | 2.51 |
| ESR1 SRX1469949 | MCF-7 Breast | 123 / 11500 (1.1%) | 5715 / 115000 (5.0%) | −110.2 | −108.3 | 0.22 |
| ESR1 SRX10365558 | MCF-7 Breast | 153 / 11500 (1.3%) | 6272 / 115000 (5.5%) | −110.1 | −108.2 | 0.24 |
| FOXA1 SRX1885181 | LNCAP Prostate | 211 / 11500 (1.8%) | 7293 / 115000 (6.3%) | −109.9 | −108.1 | 0.29 |
| ERG SRX063922 | K-562 Blood | 1078 / 11500 (9.4%) | 4862 / 115000 (4.2%) | −109.9 | −108.1 | 2.22 |
| ESR1 SRX792933 | LY2 Breast | 187 / 11500 (1.6%) | 6876 / 115000 (6.0%) | −109.9 | −108.0 | 0.27 |
| ESR1 SRX4451212 | MCF-7 Breast | 224 / 11500 (1.9%) | 7509 / 115000 (6.5%) | −109.8 | −107.9 | 0.30 |
| SREBF2 SRX5359049 | HCC70 Breast | 831 / 11500 (7.2%) | 3259 / 115000 (2.8%) | −109.7 | −107.8 | 2.55 |
| EP300 SRX100544 | Hep G2 Liver | 174 / 11500 (1.5%) | 6639 / 115000 (5.8%) | −109.7 | −107.8 | 0.26 |
| EP300 SRX1012644 | MCF-7 Breast | 90 / 11500 (0.8%) | 5040 / 115000 (4.4%) | −109.6 | −107.8 | 0.18 |
| AR SRX15946405 | MDA-MB-453 Breast | 143 / 11500 (1.2%) | 6072 / 115000 (5.3%) | −109.6 | −107.7 | 0.24 |
| FOXA1 SRX9604646 | LNCAP Prostate | 335 / 11500 (2.9%) | 9287 / 115000 (8.1%) | −109.5 | −107.7 | 0.36 |
| SMARCA4 SRX5982340 | A549 Lung | 80 / 11500 (0.7%) | 4829 / 115000 (4.2%) | −109.5 | −107.6 | 0.17 |
| ESR1 SRX1012629 | MCF-7 Breast | 138 / 11500 (1.2%) | 5974 / 115000 (5.2%) | −109.4 | −107.5 | 0.23 |
| EP300 SRX717859 | HeLa Uterus | 111 / 11500 (1.0%) | 5453 / 115000 (4.7%) | −109.3 | −107.4 | 0.20 |
| SMARCA4 SRX8566546 | 786-O Kidney | 866 / 11500 (7.5%) | 16741 / 115000 (14.6%) | −109.2 | −107.4 | 0.52 |
| FOXA1 SRX1885184 | LNCAP Prostate | 221 / 11500 (1.9%) | 7436 / 115000 (6.5%) | −109.2 | −107.3 | 0.30 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 261 / 11500 (2.3%) | 8100 / 115000 (7.0%) | −109.2 | −107.3 | 0.32 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 158 / 11500 (1.4%) | 6335 / 115000 (5.5%) | −109.1 | −107.3 | 0.25 |
| AR SRX11149848 | MDA-MB-453 Breast | 144 / 11500 (1.3%) | 6077 / 115000 (5.3%) | −109.0 | −107.2 | 0.24 |
| NR3C1 SRX10977372 | A549 Lung | 126 / 11500 (1.1%) | 5738 / 115000 (5.0%) | −109.0 | −107.1 | 0.22 |
| ESR1 SRX1012633 | MCF-7 Breast | 108 / 11500 (0.9%) | 5385 / 115000 (4.7%) | −109.0 | −107.1 | 0.20 |
| SOX5 SRX2636544 | Hep G2 Liver | 238 / 11500 (2.1%) | 7712 / 115000 (6.7%) | −108.9 | −107.0 | 0.31 |
| ZFX SRX7805372 | 293 Kidney | 1055 / 11500 (9.2%) | 4729 / 115000 (4.1%) | −108.8 | −107.0 | 2.23 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 348 / 11500 (3.0%) | 9466 / 115000 (8.2%) | −108.8 | −107.0 | 0.37 |
| JUN SRX150358 | HUVEC Cardiovascular | 139 / 11500 (1.2%) | 5977 / 115000 (5.2%) | −108.8 | −107.0 | 0.23 |
| FOXA1 SRX497612 | VCaP Prostate | 227 / 11500 (2.0%) | 7523 / 115000 (6.5%) | −108.7 | −106.9 | 0.30 |
| Epitope tags SRX5877912 | U2OS Bone | 1424 / 11500 (12.4%) | 23723 / 115000 (20.6%) | −108.7 | −106.8 | 0.60 |
| EP300 SRX22550927 | CDS1 Bone | 372 / 11500 (3.2%) | 9825 / 115000 (8.5%) | −108.7 | −106.8 | 0.38 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 285 / 11500 (2.5%) | 8471 / 115000 (7.4%) | −108.6 | −106.8 | 0.34 |
| NR3C1 SRX17639413 | A549 Lung | 155 / 11500 (1.3%) | 6263 / 115000 (5.4%) | −108.6 | −106.7 | 0.25 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 168 / 11500 (1.5%) | 6494 / 115000 (5.6%) | −108.5 | −106.7 | 0.26 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 168 / 11500 (1.5%) | 6495 / 115000 (5.6%) | −108.5 | −106.7 | 0.26 |
| FOXA2 SRX10475773 | Hep G2 Liver | 298 / 11500 (2.6%) | 8668 / 115000 (7.5%) | −108.4 | −106.6 | 0.34 |
| SS18 SRX10881848 | G-401 Kidney | 335 / 11500 (2.9%) | 9247 / 115000 (8.0%) | −108.3 | −106.5 | 0.36 |
| NANOG SRX10445309 | Neural crest cells Neural | 120 / 11500 (1.0%) | 5603 / 115000 (4.9%) | −108.3 | −106.5 | 0.21 |
| ESR1 SRX5323878 | MCF-7 Breast | 238 / 11500 (2.1%) | 7695 / 115000 (6.7%) | −108.3 | −106.5 | 0.31 |
| SMARCC1 SRX3927288 | EOL-1 Blood | 622 / 11500 (5.4%) | 13422 / 115000 (11.7%) | −108.3 | −106.5 | 0.46 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 899 / 11500 (7.8%) | 17119 / 115000 (14.9%) | −108.1 | −106.2 | 0.53 |
| CEBPB SRX2194250 | SUM 159PT Breast | 290 / 11500 (2.5%) | 8528 / 115000 (7.4%) | −108.1 | −106.2 | 0.34 |
| NR3C1 SRX2609659 | HASM2 Lung | 284 / 11500 (2.5%) | 8431 / 115000 (7.3%) | −108.0 | −106.1 | 0.34 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 210 / 11500 (1.8%) | 7213 / 115000 (6.3%) | −108.0 | −106.1 | 0.29 |
| FOXA1 SRX5203303 | MCF-7 Breast | 64 / 11500 (0.6%) | 4435 / 115000 (3.9%) | −107.9 | −106.1 | 0.14 |
| SMARCA4 SRX15419260 | 786-O Kidney | 870 / 11500 (7.6%) | 16731 / 115000 (14.5%) | −107.9 | −106.0 | 0.52 |
| NR3C1 SRX18884271 | A549 Lung | 117 / 11500 (1.0%) | 5531 / 115000 (4.8%) | −107.9 | −106.0 | 0.21 |
| LEO1 SRX1873456 | SEM Blood | 972 / 11500 (8.5%) | 4199 / 115000 (3.7%) | −107.7 | −105.9 | 2.31 |
| SPI1 SRX2770855 | Macrophages Blood | 737 / 11500 (6.4%) | 14964 / 115000 (13.0%) | −107.7 | −105.9 | 0.49 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 355 / 11500 (3.1%) | 9531 / 115000 (8.3%) | −107.7 | −105.9 | 0.37 |
| ESR1 SRX3123829 | MCF-7 Breast | 130 / 11500 (1.1%) | 5770 / 115000 (5.0%) | −107.6 | −105.8 | 0.23 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 157 / 11500 (1.4%) | 6268 / 115000 (5.5%) | −107.5 | −105.7 | 0.25 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 439 / 11500 (3.8%) | 10784 / 115000 (9.4%) | −107.5 | −105.7 | 0.41 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 285 / 11500 (2.5%) | 8425 / 115000 (7.3%) | −107.4 | −105.6 | 0.34 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 285 / 11500 (2.5%) | 8422 / 115000 (7.3%) | −107.3 | −105.4 | 0.34 |
| EP300 SRX10976215 | A549 Lung | 222 / 11500 (1.9%) | 7388 / 115000 (6.4%) | −107.2 | −105.3 | 0.30 |
| NR3C1 SRX10977357 | A549 Lung | 140 / 11500 (1.2%) | 5942 / 115000 (5.2%) | −107.1 | −105.3 | 0.24 |
| EP300 SRX1012643 | MCF-7 Breast | 70 / 11500 (0.6%) | 4537 / 115000 (3.9%) | −106.8 | −105.0 | 0.15 |
| FOXA1 SRX3931073 | MCF-7 Breast | 133 / 11500 (1.2%) | 5802 / 115000 (5.0%) | −106.7 | −104.9 | 0.23 |
| NR3C1 SRX19024866 | MCF-7 Breast | 67 / 11500 (0.6%) | 4468 / 115000 (3.9%) | −106.7 | −104.9 | 0.15 |
| NR3C1 SRX2609661 | HASM2 Lung | 276 / 11500 (2.4%) | 8257 / 115000 (7.2%) | −106.7 | −104.8 | 0.33 |
| ESR1 SRX330069 | MCF-7 Breast | 142 / 11500 (1.2%) | 5967 / 115000 (5.2%) | −106.6 | −104.8 | 0.24 |
| JUND SRX092301 | K-562 Blood | 331 / 11500 (2.9%) | 9122 / 115000 (7.9%) | −106.6 | −104.8 | 0.36 |
| Epitope tags SRX10549778 | K-562 Blood | 761 / 11500 (6.6%) | 2879 / 115000 (2.5%) | −106.6 | −104.8 | 2.64 |
| RELA SRX7055007 | HAEC Cardiovascular | 455 / 11500 (4.0%) | 10983 / 115000 (9.6%) | −106.5 | −104.7 | 0.41 |
Showing first 500 of 16758 rows.